TD Waterhouse Canada’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$496 Hold
400
﹤0.01% 2250
2026
Q1
$688 Hold
400
﹤0.01% 2132
2025
Q4
$788 Hold
400
﹤0.01% 1893
2025
Q3
$1.27K Sell
400
-30
-7% -$69 ﹤0.01% 1878
2025
Q2
$800 Buy
430
+30
+8% +$53 ﹤0.01% 1825
2025
Q1
$548 Hold
400
﹤0.01% 1793
2024
Q4
$948 Hold
400
﹤0.01% 1789
2024
Q3
$11K Hold
400
﹤0.01% 1345
2024
Q2
$4.85K Hold
400
﹤0.01% 1501
2024
Q1
$7.88K Hold
400
﹤0.01% 1414
2023
Q4
$9.38K Hold
400
﹤0.01% 1269
2023
Q3
$6.72K Hold
400
﹤0.01% 1305
2023
Q2
$9.79K Hold
400
﹤0.01% 1249
2023
Q1
$9.69K Hold
400
﹤0.01% 1228
2022
Q4
$11.1K Hold
400
﹤0.01% 1197
2022
Q3
$16.6K Hold
400
﹤0.01% 1145
2022
Q2
$10.6K Hold
400
﹤0.01% 1243
2022
Q1
$15.2K Hold
400
﹤0.01% 1237
2021
Q4
$19.3K Buy
+400
New +$21K ﹤0.01% 1217

Other funds holding FLNA

TD Waterhouse Canada's FLNA Position: Q2 2026 in Review

TD Waterhouse Canada held its Filana Therapeutics (FLNA) position steady in Q2 2026 at 400 shares worth $496. The position accounts for ﹤0.01% of the portfolio, ranked #2250.

TD Waterhouse Canada first reported a position in FLNA in Q4 2021 and has held it in 19 quarters since. The position peaked at $19.3K in Q4 2021. 14 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • TD Waterhouse Canada held 400 shares of Filana Therapeutics worth $496 as of Q2 2026.
  • TD Waterhouse Canada left its Filana Therapeutics share count unchanged in Q2 2026.
  • Filana Therapeutics made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2250 holding.
  • TD Waterhouse Canada first reported a position in Filana Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • TD Waterhouse Canada's Filana Therapeutics position peaked at $19.3K in Q4 2021.
  • 14 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.